e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Tuberculosis: from basic science to patient care
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Mycobacterium tuberculosis shape and size variations in alveolar macrophages of tuberculosis patients
E. Ufimtseva (Yekaterinburg, Russian Federation), N. Eremeeva (Yekaterinburg, Russian Federation), D. Vakhrusheva (Yekaterinburg, Russian Federation), S. Skornyakov (Yekaterinburg, Russian Federation)
Source:
International Congress 2019 – Tuberculosis: from basic science to patient care
Session:
Tuberculosis: from basic science to patient care
Session type:
Thematic Poster
Number:
4605
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Ufimtseva (Yekaterinburg, Russian Federation), N. Eremeeva (Yekaterinburg, Russian Federation), D. Vakhrusheva (Yekaterinburg, Russian Federation), S. Skornyakov (Yekaterinburg, Russian Federation). Mycobacterium tuberculosis shape and size variations in alveolar macrophages of tuberculosis patients. 4605
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Mycobacterium tuberculosis reside only inside phagosomes in alveolar macrophages of tuberculosis patients
Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools
Year: 2018
Mycobacterium tuberculosis blocks phagolysosome maturation in alveolar macrophages of tuberculosis patients
Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools
Year: 2018
Lymphocyte responses to Mycobacterium tuberculosis and Mycobacterium bovis are similar between BCG-vaccinated patients with cystic fibrosis and healthy controls
Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis
Year: 2020
Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019
A patient with cystic fibrosis and Mycobacterium abscessus infection
Source: International Congress 2018 – CC1 Lung transplantation
Year: 2018
Drug resistance of
Mycobacterium tuberculosis
isolated from tuberculosis inflammatory foci
Source: Eur Respir J 2005; 26: Suppl. 49, 654s
Year: 2005
Pulmonary tuberculosis among elderly and senile-aged patients depending on Mycobacterium strains
Source: International Congress 2017 – TB: co-morbidities and outcome
Year: 2017
Risk factors for Mycobacterium tuberculosis infection among contacts of pulmonary tuberculosis patients
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I
Year: 2012
Investigation of the inhibition of adherence of
Mycobacterium avium
complex (MAC) and
Mycobacterium tuberculosis
(MTB) to the respiratory mucosa
Source: Eur Respir J 2001; 18: Suppl. 33, 480s
Year: 2001
Sentinel-site surveillance of Mycobacterium avium complex pulmonary disease
Source: Eur Respir J 2005; 26: 1092-1096
Year: 2005
Inhaled therapies, azithromycin and Mycobacterium abscessus in cystic fibrosis patients
Source: Eur Respir J 2013; 41: 1101-1106
Year: 2013
Results of drug susceptibility testing of Mycobacterium tuberculosis isolated from sputum and surgical material from pulmonary tuberculosis patients
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
Mycobacterium tuberculosis modulates mitochondrial function in human macrophages
Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection
Year: 2020
Mycobacterium tuberculosis modulates mitochondrial function in human macrophages
Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery
Year: 2021
Antibody testing for Mycobacterium avium complex infection in cystic fibrosis patients
Source: International Congress 2018 – Cystic fibrosis: microbiological aspects and new treatments
Year: 2018
Immunological differences between lung tuberculosis and latent tuberculosis infection
Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools
Year: 2018
Mycobacterium tuberculosis DNA detection in urine samples from pulmonary tuberculosis patients
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008
Infection of the respiratory mucosa by
Mycobacterium avium
complex (MAC),
Mycobacterium tuberculosis
(MTB) and
Mycobacterium smegmatis
(MS)
Source: Eur Respir J 2001; 18: Suppl. 33, 308s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept